Collaboration overview
R&D collaboration with best plastic surgeons in the field of wound healing on the research and commercialization of the biologic EGF product developed by Daewoong Pharma which is the first of its kind in Korea
Benefits to Daewoong Pharma
- Expansion of indications reflecting actual physicians’/ patients’ unmet needs and development of new products
- Creation of new EGF market through obtaining clinical research data
Benefits to partners
- Reflection of the needs of patient therapy by participating in clinical and commercialization stages from the initial development of product
- Expansion of research in the field of wound healing, and royalty based on the sales of a new product